InvestorsHub Logo
icon url

jbog

03/11/17 1:58 PM

#16995 RE: mouton29 #16994

mouton,

Pfizer is a very good producer, not that I would say they're in the upper echelon, but not far behind.

When they announce their acquisition of Hospira I think I even mentioned on IH that it really is a step backwards for Pfizer. What we're seeing in Kansas is that "Old Habits" are really hard to break.

Hospira's niche always was basically as a hospital supply company dealing in the items you'd see in a operating or hospital room. Saline's, infusion pumps, monitoring equipment etc. They eventually were forced to be a low cost producer because price mattered when going against foreign producers.

Hospira still has to operate in a low cost environment so Pfizer's higher cost policies constantly collide together.

icon url

biopearl

03/12/17 4:44 PM

#17002 RE: mouton29 #16994

mouton, it's interesting the center one link does not even list the Kansas facility! bp